Sign In
Buy INMD
$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
InMode to Present at 2024 Baird Global Healthcare Conference
08:30am, Wednesday, 04'th Sep 2024
YOKNEAM, Israel , Sept. 4, 2024 /PRNewswire/ -- InMode Ltd.
InMode to Present at Upcoming Investor Conferences
08:30am, Tuesday, 06'th Aug 2024
YOKNEAM, Israel , Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor con
InMode Ltd. (INMD) Q2 2024 Earnings Call Transcript
11:19am, Thursday, 01'st Aug 2024
Start Time: 08:30 January 1, 0000 9:07 AM ET InMode Ltd. (NASDAQ:INMD ) Q2 2024 Earnings Conference Call August 01, 2024, 08:30 AM ET Company Participants Moshe Mizrahy - CEO Michael Kreindel - Co-Fou
InMode (INMD) Q2 Earnings and Revenues Top Estimates
09:15am, Thursday, 01'st Aug 2024
InMode (INMD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.72 per share a year ago.
YOKNEAM, Israel, Aug. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results fo
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
08:03am, Wednesday, 31'st Jul 2024
IRVINE, Calif. , July 31, 2024 /PRNewswire/ -- InMode Ltd.
Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for
11:08am, Thursday, 25'th Jul 2024
InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
08:15am, Thursday, 25'th Jul 2024
Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Opportunity to Create Shareholder Return MIAMI , July 25,
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
08:03am, Wednesday, 17'th Jul 2024
IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd.
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
08:30am, Thursday, 11'th Jul 2024
Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma Revenue (including new platform pre-orders) Between $102.4M-$102.5M, Decreases FY 2024 Guidance to $430M-$440M Conference call to be held on Thur
3 MedTech Stocks to Buy for Healthy Gains
06:00am, Monday, 01'st Jul 2024
Fundamentally, few sectors exist outside of the broad healthcare umbrella that offer what I would term permanent relevance. In this case, the concept of caring for other people is likely an eternal on
InMode: Reversing Previous Shareholder Dilution With Buybacks
11:49am, Thursday, 13'th Jun 2024
Shareholders of InMode Ltd. have seen a 46% decline in value due to slowing sales and capital allocation uncertainties. Sales growth has been impacted by rising interest rates affecting leasing deals,
InMode to Present at Jefferies Healthcare Conference
08:00am, Thursday, 16'th May 2024
YOKNEAM, Israel , May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer and Sp
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand
08:03am, Wednesday, 08'th May 2024
IRVINE, Calif. , May 8, 2024 /PRNewswire/ -- InMode Ltd.
InMode (INMD) Q1 Earnings and Revenues Beat Estimates
10:31am, Thursday, 02'nd May 2024
InMode (INMD) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.52 per share a year ago.
